Why I’d sell Rotork plc and Spirax-Sarco Engineering plc after today’s results

Rotork plc (LON: ROR) and Spirax-Sarco Engineering plc (LON: SPX) appear to be overvalued.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Two engineering stocks reporting today, Rotork (LSE: ROR) and Spirax-Sarco (LSE: SPX), have delivered impressive results. Both companies are moving in the right direction and are on track to meet expectations, at the very least. However, neither of them have investment appeal for the long term, since they trade on valuations which more than adequately factor in their upbeat outlooks.

Margins under pressure

Rotork’s third quarter performance was broadly the same as in the first half of the year. On an organic constant currency basis, Rotork’s revenue increased by 5.3% versus the same period of last year. Its investment in infrastructure has improved its operational performance, while its cost reduction programme is also progressing well.

In terms of its reported sales growth, Rotork’s top line rose by 28.9%. This benefited from weaker sterling and the contribution from acquisitions. In fact, currency changes are now expected to deliver a 10% benefit to both full year revenue and profit. However, Rotork continues to experience a challenging trading environment. This is causing margins to come under pressure, with this situation likely to continue over the medium term.

What a drag

It’s a similar story for Spirax-Sarco. The global macroeconomic environment remains in the low-to-no growth situation that was a key theme of 2015 and the first half of 2016. As a result, the company’s organic sales growth in the first ten months of the year slowed modestly from that achieved in the first half of the year as several large projects were not repeated.

Even though it faces a tough operating environment, Spirax-Sarco is on track to meet full year expectations. Its performance will benefit from a revised strategy, which seeks to deliver improved performance versus its markets through being more effective in identifying and generating engineered solutions to help customers with sustainability, efficiency and productivity. As such, Spirax-Sarco appears to be well-placed on a relative basis, although a poor trading environment is likely to be a drag on performance.

Uncertain outlook

Looking ahead, Rotork is forecast to increase its earnings by 7% in the next financial year, while Spirax-Sarco’s bottom line is expected to rise by 11%. Both of these figures are highly impressive given the challenges they face. They show that the two companies have the right strategies and sound business models, which bodes well for the long term.

However, the market appears to have already priced in their upbeat performance. In Rotork’s case, it trades on a price-to-earnings growth (PEG) ratio of 3.1, while Spirax-Sarco’s PEG ratio is 2.1. Both of these figures lack appeal and indicate that there is little, if any, margin of safety on offer.

Given the uncertain outlook both companies face and their somewhat modest underlying growth rates, this means that neither of them offers investment appeal at the present time. As such, it may be best to look elsewhere for more favourable risk/reward ratios.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has recommended Rotork. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »